Literature DB >> 589599

Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer.

R T Eagan, J N Ingle, S Frytak, J Rubin, L K Kvols, D T Carr, D T Coles, J R O'Fallon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 589599

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  13 in total

Review 1.  Chemotherapy in non-small cell lung cancer.

Authors:  C J Sweeney; A B Sandler
Journal:  Invest New Drugs       Date:  2000-05       Impact factor: 3.850

2.  High-dose methotrexate with citrovorum factor rescue in non-small-cell lung cancer.

Authors:  F A Greco; M F Fer; R L Richardson; K R Hande; C J Van Boxtel; R K Oldham
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

Review 3.  Combination chemotherapy for advanced adenocarcinoma of the lung. A review.

Authors:  J B Sørensen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 4.  Chemotherapy of advanced non-small cell lung cancer. A review.

Authors:  B J Takasugi; T P Miller
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

5.  Chemotherapy of non-small cell lung cancer: clinical trials at the Memorial Sloan-Kettering Cancer Center.

Authors:  R J Gralla; R E Wittes; E S Casper; D P Kelsen; E Cvitkovic; G B Magill; S E Krown; R B Golbey
Journal:  World J Surg       Date:  1981-09       Impact factor: 3.352

6.  Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer.

Authors:  P Drings; U Abel; H Bülzebruck; P Stiefel; M Kleckow; H G Manke
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 7.  Update in cancer chemotherapy, Part III: Lung cancer, Part 1.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1985-10       Impact factor: 1.798

Review 8.  Single-agent chemotherapy for advanced adenocarcinoma of the lung. A review.

Authors:  J B Sørensen; M Clerici; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 9.  Is there a role for vindesine in the treatment of non-small cell lung cancer?

Authors:  J B Sørensen; H H Hansen
Journal:  Invest New Drugs       Date:  1993 May-Aug       Impact factor: 3.850

10.  Alkylation by 1,2:5,6-dianhydrogalactitol of deoxyribonucleic acid and guanosine.

Authors:  E Institóris; J Tamás
Journal:  Biochem J       Date:  1980-03-01       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.